VISIONAERIE Trademark

Trademark Overview

On Thursday, February 16, 2017, a trademark application was filed for VISIONAERIE with the United States Patent and Trademark Office. The USPTO has given the VISIONAERIE trademark a serial number of 87338490. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2019. This trademark is owned by Aerie Pharmaceuticals, Inc.. The VISIONAERIE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

PROVIDER OF RESEARCH AND DEVELOPMENT SERVICES IN THE FIELDS OF OPHTHALMOLOGY, MEDICINAL CHEMISTRY, CELL BIOLOGY, AND PHARMACOLOGY; CONDUCTING RESEARCH AND CLINICAL TRIALS FOR OTHERS RELATING TO PHARMACEUTICALS IN THE FIELDS OF OPHTHALMOLOGY, MEDICINAL CHEMISTRY, CELL BIOLOGY, AND PHARMACOLOGY
visionaerie

General Information

Serial Number87338490
Word MarkVISIONAERIE
Filing DateThursday, February 16, 2017
Status700 - REGISTERED
Status DateTuesday, July 9, 2019
Registration Number5800834
Registration DateTuesday, July 9, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 24, 2018

Trademark Statements

Pseudo MarkVISION AERIE; VISIONARY
Goods and ServicesPROVIDER OF RESEARCH AND DEVELOPMENT SERVICES IN THE FIELDS OF OPHTHALMOLOGY, MEDICINAL CHEMISTRY, CELL BIOLOGY, AND PHARMACOLOGY; CONDUCTING RESEARCH AND CLINICAL TRIALS FOR OTHERS RELATING TO PHARMACEUTICALS IN THE FIELDS OF OPHTHALMOLOGY, MEDICINAL CHEMISTRY, CELL BIOLOGY, AND PHARMACOLOGY

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 23, 2017
Primary Code042
First Use Anywhere DateTuesday, January 16, 2018
First Use In Commerce DateTuesday, January 16, 2018

Trademark Owner History

Party NameALCON INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFribourg CH-1701
CH
Party NameAerie Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921

Trademark Events

Event DateEvent Description
Friday, February 24, 2017NOTICE OF PSEUDO MARK E-MAILED
Wednesday, August 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 20, 2017NEW APPLICATION ENTERED
Thursday, February 23, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 11, 2017ASSIGNED TO EXAMINER
Tuesday, May 16, 2017NON-FINAL ACTION WRITTEN
Tuesday, May 16, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 16, 2017NON-FINAL ACTION E-MAILED
Wednesday, August 16, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 20, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 8, 2017FINAL REFUSAL WRITTEN
Friday, September 8, 2017FINAL REFUSAL E-MAILED
Friday, September 8, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, March 5, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, March 16, 2018ASSIGNED TO LIE
Monday, March 19, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 5, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 24, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 19, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 16, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, October 16, 2018USE AMENDMENT FILED
Wednesday, November 14, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 14, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 5, 2018SU - NON-FINAL ACTION - WRITTEN
Wednesday, December 5, 2018NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 3, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 4, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 9, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, March 22, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 29, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 29, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 9, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

visionaerie medicinal chemistry biology pharmacology ophthalmology cell research fields others relating